1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Urine Analysis - Pipeline Review, 2015

Urine Analysis - Pipeline Review, 2015

  • September 2015
  • -
  • Global Data
  • -
  • 72 pages

Urine Analysis - Pipeline Review, 2015

Summary

GlobalData's Medical Devices sector report, “Urine Analysis - Pipeline Review, 2015" provides an overview of Urine Analysis products currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Urine Analysis pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Urine Analysis products under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Urine Analysis products and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Urine Analysis products under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table Of Contents

Urine Analysis - Pipeline Review, 2015
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Urine Analysis Overview 6
3 Products under Development 7
3.1 Urine Analysis - Pipeline Products by Stage of Development 7
3.2 Urine Analysis - Pipeline Products by Segment 8
3.3 Urine Analysis - Pipeline Products by Territory 9
3.4 Urine Analysis - Pipeline Products by Regulatory Path 10
3.5 Urine Analysis - Pipeline Products by Estimated Approval Date 11
3.6 Urine Analysis - Ongoing Clinical Trials 12
4 Urine Analysis - Pipeline Products under Development by Companies 13
4.1 Urine Analysis Companies - Pipeline Products by Stage of Development 13
4.2 Urine Analysis - Pipeline Products by Stage of Development 14
5 Urine Analysis Companies and Product Overview 15
5.1 Analyticon Biotechnologies AG Company Overview 15
5.1.1 Analyticon Biotechnologies AG Pipeline Products and Ongoing Clinical Trials Overview 15
5.2 Arkray, Inc. Company Overview 17
5.2.1 Arkray, Inc. Pipeline Products and Ongoing Clinical Trials Overview 17
5.3 Biosense Technologies Pvt Ltd. Company Overview 19
5.3.1 Biosense Technologies Pvt Ltd. Pipeline Products and Ongoing Clinical Trials Overview 19
5.4 California Pacific Medical Center Research Institute Company Overview 22
5.4.1 California Pacific Medical Center Research Institute Pipeline Products and Ongoing Clinical Trials Overview 22
5.5 Erba Diagnostics, Inc. Company Overview 23
5.5.1 Erba Diagnostics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 23
5.6 Imagnus Biomedical Inc. Company Overview 25
5.6.1 Imagnus Biomedical Inc. Pipeline Products and Ongoing Clinical Trials Overview 25
5.7 Imperial College London Company Overview 26
5.7.1 Imperial College London Pipeline Products and Ongoing Clinical Trials Overview 26
5.8 IRIS International, Inc. Company Overview 27
5.8.1 IRIS International, Inc. Pipeline Products and Ongoing Clinical Trials Overview 27
5.9 LifeAssays AB Company Overview 28
5.9.1 LifeAssays AB Pipeline Products and Ongoing Clinical Trials Overview 28
5.10 Roche Diagnostics International Ltd. Company Overview 30
5.10.1 Roche Diagnostics International Ltd. Pipeline Products and Ongoing Clinical Trials Overview 30
5.11 Scanadu HQ Company Overview 32
5.11.1 Scanadu HQ Pipeline Products and Ongoing Clinical Trials Overview 32
5.12 Shenzhen Genius Electronics Co., Ltd. Company Overview 33
5.12.1 Shenzhen Genius Electronics Co., Ltd. Pipeline Products and Ongoing Clinical Trials Overview 33
5.13 Siemens Healthcare Diagnostics Inc. Company Overview 35
5.13.1 Siemens Healthcare Diagnostics Inc. Pipeline Products and Ongoing Clinical Trials Overview 35
5.14 Stanford University Company Overview 36
5.14.1 Stanford University Pipeline Products and Ongoing Clinical Trials Overview 36
5.15 Svenska Cellulosa Aktiebolaget Company Overview 37
5.15.1 Svenska Cellulosa Aktiebolaget Pipeline Products and Ongoing Clinical Trials Overview 37
5.16 Sysmex Corporation Company Overview 39
5.16.1 Sysmex Corporation Pipeline Products and Ongoing Clinical Trials Overview 39
5.17 Teco Diagnostics Company Overview 41
5.17.1 Teco Diagnostics Pipeline Products and Ongoing Clinical Trials Overview 41
5.18 University of California, San Francisco Company Overview 42
5.18.1 University of California, San Francisco Pipeline Products and Ongoing Clinical Trials Overview 42
5.19 University of Kentucky Company Overview 44
5.19.1 University of Kentucky Pipeline Products and Ongoing Clinical Trials Overview 44
5.20 University of Maryland, Baltimore Company Overview 45
5.20.1 University of Maryland, Baltimore Pipeline Products and Ongoing Clinical Trials Overview 45
6 Urine Analysis- Recent Developments 46
7 Appendix 69
7.1 Methodology 69
7.2 About GlobalData 71
7.3 Contact Us 72
7.4 Disclaimer 72

1.1 List of Tables
Table 1: Urine Analysis - Pipeline Products by Stage of Development 7
Table 2: Urine Analysis - Pipeline Products by Segment 8
Table 3: Urine Analysis - Pipeline Products by Territory 9
Table 4: Urine Analysis - Pipeline Products by Regulatory Path 10
Table 5: Urine Analysis - Pipeline Products by Estimated Approval Date 11
Table 6: Urine Analysis - Ongoing Clinical Trials 12
Table 7: Urine Analysis Companies - Pipeline Products by Stage of Development 13
Table 8: Urine Analysis - Pipeline Products by Stage of Development 14
Table 9: Analyticon Biotechnologies AG Pipeline Products and Ongoing Clinical Trials Overview 15
Table 10: CombiScan XL - Product Status 16
Table 11: CombiScan XL - Product Description 16
Table 12: Arkray, Inc. Pipeline Products and Ongoing Clinical Trials Overview 17
Table 13: AUTION ELEVEN AE-4020 Urine Chemistry Analyzer - Product Status 18
Table 14: AUTION ELEVEN AE-4020 Urine Chemistry Analyzer - Product Description 18
Table 15: Biosense Technologies Pvt Ltd. Pipeline Products and Ongoing Clinical Trials Overview 19
Table 16: uChek Universal - Product Status 19
Table 17: uChek Universal - Product Description 19
Table 18: Biosense Technologies Pvt Ltd. - Ongoing Clinical Trials Overview 20
Table 19: uChek Universal - A Prospective Observational Pilot Study to Test the Feasibility of Smartphone Enabled uChek Urinalysis Device in Bangladesh 21
Table 20: California Pacific Medical Center Research Institute Pipeline Products and Ongoing Clinical Trials Overview 22
Table 21: Urinary Proteome Monitoring Assay - Product Status 22
Table 22: Urinary Proteome Monitoring Assay - Product Description 22
Table 23: Erba Diagnostics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 23
Table 24: Laura XL - Product Status 24
Table 25: Laura XL - Product Description 24
Table 26: Imagnus Biomedical Inc. Pipeline Products and Ongoing Clinical Trials Overview 25
Table 27: UrMeter - Product Status 25
Table 28: UrMeter - Product Description 25
Table 29: Imperial College London Pipeline Products and Ongoing Clinical Trials Overview 26
Table 30: Diagnostic Test - Autism - Product Status 26
Table 31: Diagnostic Test - Autism - Product Description 26
Table 32: IRIS International, Inc. Pipeline Products and Ongoing Clinical Trials Overview 27
Table 33: 3GEMS Next Generation Urinalysis Platform - Product Status 27
Table 34: 3GEMS Next Generation Urinalysis Platform - Product Description 27
Table 35: LifeAssays AB Pipeline Products and Ongoing Clinical Trials Overview 28
Table 36: LifeAssays U-Albumin - Product Status 29
Table 37: LifeAssays U-Albumin - Product Description 29
Table 38: Roche Diagnostics International Ltd. Pipeline Products and Ongoing Clinical Trials Overview 30
Table 39: Cobas 6500 Analyzer - Product Status 31
Table 40: Cobas 6500 Analyzer - Product Description 31
Table 41: Scanadu HQ Pipeline Products and Ongoing Clinical Trials Overview 32
Table 42: Scanadu Urine - Product Status 32
Table 43: Scanadu Urine - Product Description 32
Table 44: Shenzhen Genius Electronics Co., Ltd. Pipeline Products and Ongoing Clinical Trials Overview 33
Table 45: Auto Urine Analyzer - Product Status 33
Table 46: Auto Urine Analyzer - Product Description 33
Table 47: Urine Sediment Analyzer - Product Status 34
Table 48: Urine Sediment Analyzer - Product Description 34
Table 49: Siemens Healthcare Diagnostics Inc. Pipeline Products and Ongoing Clinical Trials Overview 35
Table 50: Clinitek Atlas Next - Product Status 35
Table 51: Clinitek Atlas Next - Product Description 35
Table 52: Stanford University Pipeline Products and Ongoing Clinical Trials Overview 36
Table 53: Biostrip Test - Urine Analysis - Product Status 36
Table 54: Biostrip Test - Urine Analysis - Product Description 36
Table 55: Svenska Cellulosa Aktiebolaget Pipeline Products and Ongoing Clinical Trials Overview 37
Table 56: U-Check Alarm - Product Status 38
Table 57: U-Check Alarm - Product Description 38
Table 58: Sysmex Corporation Pipeline Products and Ongoing Clinical Trials Overview 39
Table 59: Sysmex UX-2000 Integrated Urinalysis Instrument - Product Status 40
Table 60: Sysmex UX-2000 Integrated Urinalysis Instrument - Product Description 40
Table 61: Teco Diagnostics Pipeline Products and Ongoing Clinical Trials Overview 41
Table 62: Next Generation Urine Analyzer - Product Status 41
Table 63: Next Generation Urine Analyzer - Product Description 41
Table 64: University of California, San Francisco Pipeline Products and Ongoing Clinical Trials Overview 42
Table 65: Steroid Detection Assay - Product Status 43
Table 66: Steroid Detection Assay - Product Description 43
Table 67: University of Kentucky Pipeline Products and Ongoing Clinical Trials Overview 44
Table 68: Diagnostic Gene-Expression Test - Interstitial Cystitis - Product Status 44
Table 69: Diagnostic Gene-Expression Test - Interstitial Cystitis - Product Description 44
Table 70: University of Maryland, Baltimore Pipeline Products and Ongoing Clinical Trials Overview 45
Table 71: Diagnostic Test - Interstitial Cystitis - Product Status 45
Table 72: Diagnostic Test - Interstitial Cystitis - Product Description 45
Table 73: Glossary 70

1.2 List of Figures
Figure 1: Urine Analysis - Pipeline Products by Stage of Development 7
Figure 2: Urine Analysis - Pipeline Products by Segment 8
Figure 3: Urine Analysis - Pipeline Products by Territory 9
Figure 4: Urine Analysis - Pipeline Products by Regulatory Path 10
Figure 5: Urine Analysis - Pipeline Products by Estimated Approval Date 11
Figure 6: Urine Analysis - Ongoing Clinical Trials 12

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.